These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2095212)
1. Evaluation of iodovinyl antibody conjugates: comparison with a p-iodobenzoyl conjugate and direct radioiodination. Hadley SW; Wilbur DS Bioconjug Chem; 1990; 1(2):154-61. PubMed ID: 2095212 [TBL] [Abstract][Full Text] [Related]
2. Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab. Wilbur DS; Hadley SW; Grant LM; Hylarides MD Bioconjug Chem; 1991; 2(2):111-6. PubMed ID: 1868113 [TBL] [Abstract][Full Text] [Related]
3. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925 [TBL] [Abstract][Full Text] [Related]
4. Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate. Hadley SW; Wilbur DS; Gray MA; Atcher RW Bioconjug Chem; 1991; 2(3):171-9. PubMed ID: 1932216 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments. Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742 [TBL] [Abstract][Full Text] [Related]
6. Preparation and in vivo evaluation of an N-(p-[125I]iodophenethyl)maleimide-antibody conjugate. Hylarides MD; Wilbur DS; Reed MW; Hadley SW; Schroeder JR; Grant LM Bioconjug Chem; 1991; 2(6):435-40. PubMed ID: 1805941 [TBL] [Abstract][Full Text] [Related]
7. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate. Vaidyanathan G; Affleck DJ; Zalutsky MR Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137 [TBL] [Abstract][Full Text] [Related]
8. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention. Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347 [TBL] [Abstract][Full Text] [Related]
9. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. Wilbur DS; Hadley SW; Hylarides MD; Abrams PG; Beaumier PA; Morgan AC; Reno JM; Fritzberg AR J Nucl Med; 1989 Feb; 30(2):216-26. PubMed ID: 2738650 [TBL] [Abstract][Full Text] [Related]
10. Catabolism of radioiodinated murine monoclonal antibody F(ab')2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods. Garg PK; Alston KL; Zalutsky MR Bioconjug Chem; 1995; 6(4):493-501. PubMed ID: 7578370 [TBL] [Abstract][Full Text] [Related]
11. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications. Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481 [TBL] [Abstract][Full Text] [Related]
13. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate. Zalutsky MR; Narula AS Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515 [TBL] [Abstract][Full Text] [Related]
14. Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability. Garg PK; Slade SK; Harrison CL; Zalutsky MR Int J Rad Appl Instrum B; 1989; 16(7):669-73. PubMed ID: 2613522 [TBL] [Abstract][Full Text] [Related]
15. Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in a murine lymphoma model. Badger CC; Wilbur DS; Hadley SW; Fritzberg AR; Bernstein ID Int J Rad Appl Instrum B; 1990; 17(4):381-7. PubMed ID: 2387747 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of radioiodinated and radiocopper labeled monovalent fragments of monoclonal antibody chCE7 for targeting of neuroblastoma. Carrel F; Amstutz H; Novak-Hofer I; Schubiger PA Nucl Med Biol; 1997 Aug; 24(6):539-46. PubMed ID: 9316082 [TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points. Kobayashi H; Le N; Kim IS; Kim MK; Pie JE; Drumm D; Paik DS; Waldmann TA; Paik CH; Carrasquillo JA Cancer Res; 1999 Jan; 59(2):422-30. PubMed ID: 9927057 [TBL] [Abstract][Full Text] [Related]
18. Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labeling using N-succinimidyl-3-(tri-n-butylstannyl)benzoate conjugate. Chen J; Strand SE; Sjögren HO Cancer Biother Radiopharm; 1996 Jun; 11(3):217-26. PubMed ID: 10851540 [TBL] [Abstract][Full Text] [Related]
19. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments. Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348 [TBL] [Abstract][Full Text] [Related]
20. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies. Garg PK; Garg S; Zalutsky MR Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]